P&T pays tribute to a long-time columnist and medical writer, Lawrence Prescott, PhD.
You are here
P&T® Journal contents for April 2007
As with many well-intentioned feel-good initiatives, achieving the goals of the Medication Reconciliation Project will be a lot more difficult than dreaming them up.
Stimulant drugs, considered a first-line therapy for ADHD, have a potential for misuse and abuse. A new agent may have less potential for these problems.
An Evaluation of Off-Label Use of Recombinant Activated Human Factor VII (NovoSeven): Patient Characteristics, Utilization Trends, and Outcomes from an Electronic Database of U.S. Academic Health Centers
As a therapy for bleeding, rFVIIa is often prescribed for off-label indications, and this trend is increasing. The authors suggest possible new prescribing guidelines.
The author reviews therapies for multiple myeloma, chronic myeloid leukemia, paroxysmal nocturnal hemolysis, and B-cell chronic lymphocytic leukemia.